OverviewChartNewsTraderScreen

BioElectronics Corp/  US09062H1086  /

Nasdaq Other OTC
2024-04-17  9:21:57 PM Chg. -0.0001 Volume Bid- Ask- High Low
0.0002USD -33.33% 6.63 mill.
Turnover: 1,336.0684		 -Bid Size: - -Ask Size: - 0.0003 0.0001
GlobeNewswire 03-25 BioElectronics Corporation Announces the Publication of a Canine Arthritis Study
GlobeNewswire 02-23 BioElectronics Corporation Announces the Publication of Pilot Study Results
GlobeNewswire 02-15 BioElectronics Chairman Updates Investors
GlobeNewswire 02-02 Pixium Vision announces the rejection of the sale plan (plan de cession) by the Court and the conver...
GlobeNewswire 01-18 NeuroSigma Announces FDA Clearance of its Second-Generation Monarch eTNS System for Treating Pediatr...
GlobeNewswire 01-17 Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of jud...
GlobeNewswire 01-17 Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of jud...
GlobeNewswire 2023-12-22 End of Year Message From the Chairman of the Board of BioElectronics
GlobeNewswire 2023-12-18 Decision concerning the adoption of a sale plan (plan de cession) and the opening of judicial liquid...
GlobeNewswire 2023-12-04 Commercial Court hearing to examine the takeover offer scheduled for December 18, 2023
GlobeNewswire 2023-11-20 Update on the receivership proceedings: submission of a takeover offer to the court-appointed admini...
GlobeNewswire 2023-11-14 Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD
GlobeNewswire 2023-11-13 Pixium Vision announces the conversion of the safeguard proceedings into receivership
GlobeNewswire 2023-11-07 NeuroSigma Announces FDA 510(k) Submission for Second Generation Monarch eTNS System
GlobeNewswire 2023-10-26 Pixium Vision announces its financial results for H1 2023 and provides update
GlobeNewswire 2023-10-18 Pixium Vision announces the launch of a process to find buyers
GlobeNewswire 2023-10-09 Pixium Vision announces the opening of safeguard proceedings
GlobeNewswire 2023-10-03 NeuroSigma Announces HSA Approval of the Monarch eTNS System in Singapore
GlobeNewswire 2023-09-20 Pixium Vision announces the completion of the reverse stock split of its shares on the basis of 1 ne...
GlobeNewswire 2022-03-29 Pixium Vision announces FDA approval of clinical trial expansion of Prima System US feasibility stud...
GlobeNewswire 2022-03-24 Pixium Vision to participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and ...
GlobeNewswire 2022-03-14 Pixium Vision convenes a Combined General Meeting of Shareholders on April 19, 2022
GlobeNewswire 2022-02-28 BioElectronics Corporation Chairman Richard Staelin, Ph.D., Updates Company Achievements
GlobeNewswire 2022-01-27 Pixium Vision announces the publication in Nature Communications of peer-reviewed clinical data demo...
GlobeNewswire 2022-01-26 Ignis Therapeutics Licenses NeuroSigma eTNS Technology for ADHD in a Significant China Licensing Tra...